Blurred vision: Difference between revisions
Jump to navigation
Jump to search
Golnaz Holm (talk | contribs) No edit summary |
Golnaz Holm (talk | contribs) No edit summary |
||
| Line 5: | Line 5: | ||
<br /> | <br /> | ||
==Overview== | ==Overview== | ||
Blurred vision is a common [[ocular]] [[symptom]] which is define as a sudden or gradual loss of clarity or [[sharpness of vision]] and difficulty to see fine details.It can present [[unilateral]] or [[bilateral]]. | Blurred vision is a common [[ocular]] [[symptom]] which is define as a sudden or gradual loss of clarity or [[sharpness of vision]] and difficulty to see fine details.It can present [[ unilateral]] or [[bilateral]]. | ||
==Historical Perspective== | ==Historical Perspective== | ||
There is not much information regarding the historical perspective of blurred vision. | There is not much information regarding the historical perspective of blurred vision. | ||
| Line 11: | Line 11: | ||
There is no established system for the classification of blurred vision. | There is no established system for the classification of blurred vision. | ||
==Pathophysiology== | ==Pathophysiology== | ||
Blurred vision may result from [[refractive errors]], opacity of structures ([[lens]], [[cornea]], [[vitreous]]), [[retina]] disorder or [[optic nerve]] disease. | Blurred vision may result from [[refractive errors ]], opacity of structures ([[lens]], [[cornea]], [[vitreous]]), [[retina]] disorder or [[optic nerve]] disease. | ||
==[[blurred vision|Causes]]== | ==[[blurred vision|Causes]]== | ||
Blurred vision can be caused by a wide range of eye conditions which include: | Blurred vision can be caused by a wide range of eye conditions which include: | ||
*[[Refractive errors]] (most common) | *[[ Refractive errors]] (most common) | ||
*[[Age-related macular degeneration]] | *[[Age-related macular degeneration]] | ||
*[[Cataracts]] | *[[Cataracts]] | ||
| Line 46: | Line 46: | ||
*According to the [[American Diabetes Association’s]] patients with type 1 and type 2 diabetes should have comprehensive eye examination within 5 years after the onset of diabetes and at the time of diagnosis ,respectively. <ref>Diabetes Care. Introduction. Diabetes Care. 2010 Jan;33 Suppl 1(Suppl 1):S1-2. doi: 10.2337/dc10-S001. PMID: 20042770; PMCID: PMC2797380.</ref> The eye examination should be considered at least annually thereafter. | *According to the [[American Diabetes Association’s]] patients with type 1 and type 2 diabetes should have comprehensive eye examination within 5 years after the onset of diabetes and at the time of diagnosis ,respectively. <ref>Diabetes Care. Introduction. Diabetes Care. 2010 Jan;33 Suppl 1(Suppl 1):S1-2. doi: 10.2337/dc10-S001. PMID: 20042770; PMCID: PMC2797380.</ref> The eye examination should be considered at least annually thereafter. | ||
*There is insufficient evidence to recommend routine screening for [[Glaucoma]]. [[USPSTF]] suggests that patients at increased risk, especially African Americans and older adults, talk to their primary care clinician or eye care specialist for advice about glaucoma screening. | *There is insufficient evidence to recommend routine screening for [[Glaucoma]]. [[USPSTF]] suggests that patients at increased risk, especially African Americans and older adults, talk to their primary care clinician or eye care specialist for advice about [[glaucoma screening]]. | ||
*The USPSTF<REF>Screening for High Blood Pressure in Adults: Recommendation Statement. Am Fam Physician. 2016 Feb 15;93(4):300-2. PMID: 26926818</ref>. recommends annual screening for adults aged 40 years or older and for those who are at increased risk for [[high blood pressure]].[3] Persons at increased risk include those who have high-normal blood pressure (130 to 139/85 to 89 mm Hg), those who are [[overweight]] or obese, and African Americans. Adults aged 18 to 39 years with normal blood pressure (<130/85 mm Hg) who do not have other risk factors should be rescreened every 3 to 5 years. | *The USPSTF<REF>Screening for High Blood Pressure in Adults: Recommendation Statement. Am Fam Physician. 2016 Feb 15;93(4):300-2. PMID: 26926818</ref>. recommends annual screening for adults aged 40 years or older and for those who are at increased risk for [[high blood pressure]].[3] Persons at increased risk include those who have high-normal blood pressure (130 to 139/85 to 89 mm Hg), those who are [[overweight]] or obese, and African Americans. Adults aged 18 to 39 years with normal blood pressure (<130/85 mm Hg) who do not have other risk factors should be rescreened every 3 to 5 years. | ||
| Line 105: | Line 105: | ||
===[[Secondary Prevention]]=== | ===[[Secondary Prevention]]=== | ||
*Effective measures for the[[ secondary prevention]] of blurred vision due to [[refractive errors]] is early detection and treatment of [[refractive errors]] in [[school vision programs]]. | *Effective measures for the[[ secondary prevention]] of blurred vision due to [[refractive errors]] is early detection and treatment of [[refractive errors]] in [[school vision programs]]. | ||
*Secondary Prevention of [[Atherosclerotic Cardiovascular]] Disease includes [[lifestyle interventions]],[[weight management]],[[anti hypertensive agents]], [[stain therapy]],[[Anti- platelet]] Therapy,diabetes treatment and [[Cigarette/Tobacco Cessation]]. | *Secondary Prevention of [[Atherosclerotic Cardiovascular]] Disease includes [[lifestyle interventions]],[[weight management]],[[anti hypertensive agents]], [[stain therapy]],[[Anti- platelet]] Therapy,[[diabetes treatment]] and [[Cigarette/Tobacco Cessation]]. | ||
==References== | ==References== | ||
Revision as of 08:32, 11 April 2021
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief:
Overview
Blurred vision is a common ocular symptom which is define as a sudden or gradual loss of clarity or sharpness of vision and difficulty to see fine details.It can present unilateral or bilateral.
Historical Perspective
There is not much information regarding the historical perspective of blurred vision.
Classification
There is no established system for the classification of blurred vision.
Pathophysiology
Blurred vision may result from refractive errors , opacity of structures (lens, cornea, vitreous), retina disorder or optic nerve disease.
Causes
Blurred vision can be caused by a wide range of eye conditions which include:
- Refractive errors (most common)
- Age-related macular degeneration
- Cataracts
- Presbyopia
- Diabetes retinopathy
- Glaucoma
- Corneal abrasion or scarring; keratitis
- conjunctivitis
- Uveitis
- Iritis
- Retinal detachment
- Retinitis
- Eye trauma (Hyphema)
- Migraine
- Malignancy and tumor (Brain tumor, Lung cancer metastasis [1] ,Leukemia)
- Optic neuritis
- Cerebrovascular disease (TIA, stroke)
- Vasculitis (Temporal arteritis,SLE)
- High blood pressure
- Medication
Epidemiology and Demographics
Patients of all age groups may develop blurred vision.
Risk Factors
Risk factors in the development of blurred vision include Genetic,Family history,Diabetes mellitus,Age,Hyperlipidemia,Hypertension
Screening
- According to the American Diabetes Association’s patients with type 1 and type 2 diabetes should have comprehensive eye examination within 5 years after the onset of diabetes and at the time of diagnosis ,respectively. [2] The eye examination should be considered at least annually thereafter.
- There is insufficient evidence to recommend routine screening for Glaucoma. USPSTF suggests that patients at increased risk, especially African Americans and older adults, talk to their primary care clinician or eye care specialist for advice about glaucoma screening.
- The USPSTF[3]. recommends annual screening for adults aged 40 years or older and for those who are at increased risk for high blood pressure.[3] Persons at increased risk include those who have high-normal blood pressure (130 to 139/85 to 89 mm Hg), those who are overweight or obese, and African Americans. Adults aged 18 to 39 years with normal blood pressure (<130/85 mm Hg) who do not have other risk factors should be rescreened every 3 to 5 years.
Natural History, Complications, and Prognosis
Prognosis of blurred vision depends on the underlying cause.
Diagnosis
There are no established criteria for the diagnosis of blurred vision. The diagnosis of blurred vision is based on taking detailed medical history and eye examination.Patient Should be asked about the onset, duration, associated symptoms and whether blurred vision is bilateral or unilateral.
History and Symptoms
- The common symptoms which accompany blurred vision include Redness of the eye,Eye pain,Epiphoria,Headache,Photophobia,Halos,Nausea,Polydipsia and polyuria,Dizziness,Numbness.
- Eye examination of patients with blurred vision includes Visual acuity test,Visual fields examination,Slit lamp,Ophthalmoscopy,Tonometry,Angle Test (Gonioscopy)
- The presence of suddenhemiplegia ,abnormal gait,ataxia and dysarthria is diagnostic of cerebrovascular accident.
Laboratory Findings
- Patients with systemic disorders should have appropriate testing.
- An elevated concentration of blood sugar and HgA1C is seen in blurred vision due to diabetes mellitus.
- Urinalysis and renal function testing should be considered in patients with high blood pressure.
- Antinuclear antibodies and elevated ESR are associated with SLE and vasculitis.
- CBC with differential count and other tests are needed in some cases( Leukemia, Multiple myeleoma)
- CT scan of brain may be helpful in diagnosis of mass occupying lesions or Ischemic and hemorrhagic stroke.
- A magnetic resonance imaging (MRI) study of the brain and orbits may confirm inflammation of the optic nerve.
Treatment
Depends upon the cause, underlying disorders should be addressed.
- Patients with refractive errors andpresbyopia can be treated with Corrective lenses and eyeglasses.
- Supportive therapy for hyphema includes raising the head of the bed, wearing eye shield and cut back on physical activity.
- There is no treatment for dry macular degeneration.[4]Patients with wet macular degeneration may be treated with Anti-VEGF medications or Photodynamic therapy which help stop the growth of new blood vessels.[5]
Medical Therapy
- Medical therapy of diabetic retinopathy include direct injections or intravitreal administration of anti-inflammatory and antiangiogenesis agents(anti-VEGF drugs [6] [7]) which are widely used pharmacotherapy to effectively treat DR and diabetic macular edema (DME).[8]
- Laser treatment is an option in treatment of diabetic retinopathy.[9]
- Pharmacologic medical therapy with eye drops is recommended among patients with Glaucoma.
- The mainstay of treatment for treatment in infectious causes include antibacterial, antiviral or anti parasite agents.
- Patients with uveitis, iritis and optic neuritis can be treated with corticosteroids.
- Patients with temporal arteritis are treated with high dose of corticosteroids.
- Treatment of high blood pressure is medical therapy with anti hypertensive medications.
Surgery
- Surgical intervention like LASIK is commonly used to correct a refractive error.
- Surgery is the mainstay of treatment for cataract and retinal detachment.
- Vitrectomy is used in treatment of Diabetic retinopathy.[10]
- Different types of surgeries to treat glaucoma are Trabeculoplasty ,Iridotomy and Trabeculectomy.[11]
Primary Prevention
Preventive measures in developing diabetic retinopathy include a healthy lifestyle, controlling hypertension, stringent lipid control and periodic ophthalmic examinations. PMID: 17216945
Secondary Prevention
- Effective measures for thesecondary prevention of blurred vision due to refractive errors is early detection and treatment of refractive errors in school vision programs.
- Secondary Prevention of Atherosclerotic Cardiovascular Disease includes lifestyle interventions,weight management,anti hypertensive agents, stain therapy,Anti- platelet Therapy,diabetes treatment and Cigarette/Tobacco Cessation.
References
- ↑ Asteriou C, Konstantinou D, Kleontas A, et al. Blurred vision due to choroidal metastasis as the first manifestation of lung cancer: a case report. World J Surg Oncol. 2010;8:2. Published 2010 Jan 8. doi:10.1186/1477-7819-8-2
- ↑ Diabetes Care. Introduction. Diabetes Care. 2010 Jan;33 Suppl 1(Suppl 1):S1-2. doi: 10.2337/dc10-S001. PMID: 20042770; PMCID: PMC2797380.
- ↑ Screening for High Blood Pressure in Adults: Recommendation Statement. Am Fam Physician. 2016 Feb 15;93(4):300-2. PMID: 26926818
- ↑ Waugh N, Loveman E, Colquitt J, Royle P, Yeong JL, Hoad G, Lois N. Treatments for dry age-related macular degeneration and Stargardt disease: a systematic review. Health Technol Assess. 2018 May;22(27):1-168. doi: 10.3310/hta22270. PMID: 29846169; PMCID: PMC5994642.
- ↑ Hernández-Zimbrón LF, Zamora-Alvarado R, Ochoa-De la Paz L, Velez-Montoya R, Zenteno E, Gulias-Cañizo R, Quiroz-Mercado H, Gonzalez-Salinas R. Age-Related Macular Degeneration: New Paradigms for Treatment and Management of AMD. Oxid Med Cell Longev. 2018 Feb 1;2018:8374647. doi: 10.1155/2018/8374647. PMID: 29484106; PMCID: PMC5816845.
- ↑ Zhao Y, Singh RP. The role of anti-vascular endothelial growth factor (anti-VEGF) in the management of proliferative diabetic retinopathy. Drugs Context. 2018 Aug 13;7:212532. doi: 10.7573/dic.212532. PMID: 30181760; PMCID: PMC6113746.
- ↑ Rios A, Lopez-Galvez M, Navarro-Gil R, Verges R. Diabetic Macular Edema Pathophysiology: Vasogenic versus Inflammatory. J Diabetes Res. 2016;2016:2156273. doi: 10.1155/2016/2156273. Epub 2016 Sep 28. PMID: 27761468; PMCID: PMC5059543.
- ↑ Lu L, Jiang Y, Jaganathan R, Hao Y. Current Advances in Pharmacotherapy and Technology for Diabetic Retinopathy: A Systematic Review. J Ophthalmol. 2018 Jan 17;2018:1694187. doi: 10.1155/2018/1694187. Erratum in: J Ophthalmol. 2018 Dec 2;2018:5047142.
- ↑ Wang W, Lo ACY. Diabetic Retinopathy: Pathophysiology and Treatments. Int J Mol Sci. 2018 Jun 20;19(6):1816. doi: 10.3390/ijms19061816. PMID: 29925789; PMCID: PMC6032159.
- ↑ Oellers P, Mahmoud TH. Surgery for Proliferative Diabetic Retinopathy: New Tips and Tricks. J Ophthalmic Vis Res. 2016 Jan-Mar;11(1):93-9. doi: 10.4103/2008-322X.180697. PMID: 27195092; PMCID: PMC4860995.
- ↑ Garg A, Gazzard G. Selective laser trabeculoplasty: past, present, and future. Eye (Lond). 2018 May;32(5):863-876. doi: 10.1038/eye.2017.273. Epub 2018 Jan 5. Erratum in: Eye (Lond). 2020 Aug;34(8):1487. PMID: 29303146; PMCID: PMC5944654.